Fifteen New Faculty Members to Present Key Findings about IBD at Crohn's & Colitis Foundation of America's Advances in Inflammatory Bowel Diseases Clinical and Research Conference

NEW YORK, June 8, 2016 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) and Imedex announced today that 15 new faculty members will present clinical and research findings about Crohn's disease and ulcerative colitis during the 2016 Advances in Inflammatory Bowel Diseases Clinical and Research Conference (AIBD). AIBD is taking place in Orlando, Florida on December 8-10, 2016. For more information or to register, visit http://www.advancesinibd.com/. 

The field of inflammatory bowel diseases (IBD) is moving faster than ever before. Treatment options including emerging therapies and surgical management, and advancements in quality of care make it imperative for healthcare providers to actively participate in the discussion. AIBD is designed to meet the education needs of healthcare professionals and researchers who study and manage patients with IBD. Led by co-chairs Stephen B. Hanauer, MD, Northwestern Feinberg School of Medicine and Richard P. MacDermott, MD, Emeritus Professor of Medicine, Albany Medical Center, more than 60 expert specialists from the U.S. and abroad will lead sessions. New faculty members presenting this year include:

• Jeremy Adler, MD, MSc, C.S. Mott Children's Hospital
• Ashwin N. Ananthakrishnan, MBBS, MD, MPH, Massachusetts General Hospital
• Leonard K. Baidoo, MD, Northwestern Memorial Hospital
• Suzanne Baldivieso, BSN, RN, University of Maryland Medical Center
• Meenakshi Bewtra, MD, PhD, MPH, Hospital of the University of Pennsylvania
• Ken Cadwell, PhD, New York University School of Medicine
• Adam S. Cheifetz, MD, Beth Israel Deaconess Medical Center, Harvard Medical School
• Millie Long, MD, MPH, University of North Carolina at Chapel Hill
• Jenna Ottenheimer, MPH, PA-C, Rush University Medical Center
• Dana Philpott, MD, University of Toronto
• Jesus Rivera-Nieves, MD, University of California – San Diego
• Shehzad Z. Sheikh, PhD, University of North Carolina at Chapel Hill
• Scott A. Strong, MD, Northwestern Medicine
• Jerrold R. Turner, MD, PhD, Brigham and Women's Hospital, Harvard Medical School
• Melissa Wong, PhD, Oregon Health & Science University

"We are pleased to have 15 new faculty members join us for the conference this year," said Dr. Richard MacDermott, conference co-chair and Emeritus Professor of Medicine at Albany Medical Center.  "They are a great addition to the already outstanding faculty we have in place. In just two and half days, we cover all of the important aspects of basic and advanced care for IBD patients, as well as recent discoveries in cutting edge clinical research."

At AIBD, clinicians will gain practice-changing knowledge, which can be implemented into their practice immediately. Researchers will stay abreast of the vastly changing scientific landscape. Additionally, for the first time ever, the conference's nursing agenda, which empowers nurses and allied healthcare providers to develop best practices in interprofessional IBD patient care, will be certified by the American Academy of CME, Inc, an accredited provider of continuing nursing education.

Approximately 2,400 participants are expected to attend this year's conference, which is endorsed by the American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), North American Society for Pediatric Gastroenterology (NASPGHAN), and the British Society of Gastroenterology (BSG). The conference will be organized and certified for AMA PRA Category 1 Credits™ by Imedex, a global leader in education, and for ANCC (American Nurses Credentialing Center's Commission on Accreditation) contact hours by American  Academy of CME, Inc.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America (CCFA) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit www.ccfa.org, call 888-694-8872, or email [email protected].

About Imedex
Imedex is an industry leader in providing accredited, independent continuing medical education to health care professionals. We develop high quality scientific programming that translates the latest research into clinically relevant information. Our activities have exceptional organization and outstanding educational value, with a proven sustained impact on disease management. Our programs focus on improving patient care around the world. With over 50,000 e-learning experiences annually and more than 100,000 live meeting attendees, since 2001, Imedex truly educates the global healthcare community. At Imedex, education is the best medicine®. For more information on Imedex visit http://www.imedex.com.

SOURCE Crohn's & Colitis Foundation of America

Related Links

http://www.ccfa.org